| Entry |
|
|---|
| Name |
Dextran sulfate sodium sulfur 5 (JP18);
Dextran sulfate sodium sulfur 18 (JP18);
MDS (TN) |
|---|
| Class |
Hypolipidemic agent
DG01946 Hypolipidemic agent
|
|---|
| Remark |
| Therapeutic category: | 2189 |
| Product (DG00180): | D02141<US> D03343<JP> D06539<US> |
|
|---|
| Efficacy |
Antidyslipidemia (hypertriglyceridemic), Lipoprotein lipase (LPL) activator |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B05A BLOOD AND RELATED PRODUCTS
B05AA Blood substitutes and plasma protein fractions
B05AA05 Dextran
D03343 Dextran sulfate sodium sulfur 5 (JP18) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
218 Hyperlipidemia agents
2189 Others
D03343 Dextran sulfate sodium sulfur 5 (JP18); Dextran sulfate sodium sulfur 18 (JP18)
Drug groups [BR:br08330]
Hypolipidemic agent
DG01946 Hypolipidemic agent
D03343 Dextran sulfate sodium sulfur 5
Drug classes [BR:br08332]
Cardiovascular agent
DG01946 Hypolipidemic agent
D03343 Dextran sulfate sodium sulfur 5
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Carboxylic-ester hydrolases
LIPC
D03343 Dextran sulfate sodium sulfur 5 (JP18) <JP>
LPL
D03343 Dextran sulfate sodium sulfur 5 (JP18) <JP>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D03343 Dextran sulfate sodium sulfur 5
D03343 Dextran sulfate sodium sulfur 18
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
